GlassScriptPhysician profile
Asad Khan
NPI 1528564374
$18,690.77
in general payments reported to CMS, 2019-2025
15 companies · $5,979 in 2025
The $5,979 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.16 · 2020: $79.58 · 2021: $208 · 2022: $469 · 2023: $5,976 · 2024: $5,955 · 2025: $5,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,693 · Food and Beverage: $3,719 · Travel and Lodging: $2,698 · Consulting Fee: $2,400 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,692.92 |
| Food and Beverage | $3,719.01 |
| Travel and Lodging | $2,697.81 |
| Consulting Fee | $2,400.00 |
| Education | $399.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,414.58 | 2024-2025 | Micra, Symplicity G3, Linq II |
| Abbott Laboratories | $4,008.66 | 2021-2025 | Ensite Precision, Ensite, Coroflow |
| Pfizer INC. | $2,408.67 | 2023 | |
| Biotronik INC. | $526.91 | 2023-2025 | |
| Boston Scientific Corporation | $442.39 | 2022-2025 | Farapulse, Opticross, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $385.11 | 2023-2025 | Carto 3 |
| Atricure, INC. | $146.00 | 2025 | Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax |
| Cardiofocus, INC. | $114.26 | 2023 | Heartlight System |
| Glaxosmithkline, LLC. | $79.58 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.98 | 2023-2025 | Lifevest |
| Philips North America LLC | $34.96 | 2023 | (9520) Igt Devices Und |
| Cook Incorporated | $25.94 | 2024 | Evolution |
| Astrazeneca Pharmaceuticals LP | $24.16 | 2019 | |
| Cardiva Medical, INC. | $22.00 | 2025 | Cardiva Vascade 6/7f Vcs |
| Kestra Medical Technology Services, INC. | $20.57 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.